Get the Stockscreener App
2.17
1.88%
0.04
After Hours:
2.17
Aytu Biopharma Inc stock is traded at $2.17, with a volume of 11,174.
It is up +1.88% in the last 24 hours and up +14.21% over the past month.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
See More
Previous Close:
$2.13
Open:
$2.13
24h Volume:
11,174
Relative Volume:
0.06
Market Cap:
$19.48M
Revenue:
$66.38M
Net Income/Loss:
$-14.18M
P/E Ratio:
-0.773
EPS:
-2.8074
Net Cash Flow:
$-5.17M
1W Performance:
-0.46%
1M Performance:
+14.21%
6M Performance:
+66.92%
1Y Performance:
+17.30%
1-Day Range:
$2.11
$2.1945
1-Week Range:
$2.1001
$2.29
52-Week Range:
$0.95
$2.82
Aytu Biopharma Inc Stock (AYTU) Company Profile
Name
Aytu Biopharma Inc
Sector
Phone
(720) 437-6580
Address
7900 E. UNION AVENUE, DENVER
Compare AYTU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.17 | 21.70M | 66.38M | -14.18M | -5.17M | -2.8074 |
|
ZTS
Zoetis Inc
|
120.49 | 55.16B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.59 | 42.84B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.31 | 41.50B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.60 | 23.47B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
447.45 | 18.83B | 3.08B | 1.24B | 1.07B | 25.61 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Lake Street | Buy |
| Jun-30-25 | Initiated | Ascendiant Capital Markets | Buy |
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-29-20 | Initiated | H.C. Wainwright | Buy |
Aytu Biopharma Inc Stock (AYTU) Latest News
Regression analysis insights on Aytu BioPharma Inc. performanceMarket Rally & Daily Stock Trend Watchlist - newser.com
Is Aytu BioPharma Inc. (AY20) stock expanding market penetration2025 Market Sentiment & AI Forecasted Stock Moves - fcp.pa.gov.br
Is Aytu BioPharma Inc. stock a defensive play in 20252025 Market Trends & Technical Pattern Recognition Alerts - fcp.pa.gov.br
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025 - ACCESS Newswire
Aytu BioPharma (NASDAQ: AYTU) sets Nov. 13 call at 4:30 p.m. ET to discuss results - Stock Titan
Will Aytu BioPharma Inc. (AY20) stock profit from fiscal stimulusQuarterly Portfolio Summary & Proven Capital Preservation Tips - newser.com
Will Aytu BioPharma Inc. stock remain a Wall Street favoriteJuly 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Understanding Aytu BioPharma Inc.’s price movementTrade Risk Summary & Low Drawdown Trading Strategies - newser.com
Is Aytu BioPharma Inc. stock ready for a breakoutShare Buyback & Safe Swing Trade Setups - newser.com
Real time social sentiment graph for Aytu BioPharma Inc.Dollar Strength & Fast Moving Stock Trade Plans - newser.com
Will Aytu BioPharma Inc. stock see insider buyingEarnings Risk Summary & Real-Time Chart Breakout Alerts - newser.com
Relative strength of Aytu BioPharma Inc. in sector analysisQuarterly Portfolio Report & Community Supported Trade Ideas - newser.com
Will Aytu BioPharma Inc. stock attract more institutional investorsJuly 2025 Retail & Verified Short-Term Plans - newser.com
Published on: 2025-11-04 05:56:53 - newser.com
How Aytu BioPharma Inc. (AY20) stock moves in volatile trading sessionsJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Why Aytu BioPharma Inc. stock could outperform in 2025July 2025 Volume & Low Risk High Reward Ideas - fcp.pa.gov.br
What insider trading reveals about Aytu BioPharma Inc. stock2025 Geopolitical Influence & Technical Pattern Recognition Alerts - fcp.pa.gov.br
What MACD signals say about Aytu BioPharma Inc.July 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsMarket Performance Recap & Reliable Breakout Forecasts - newser.com
Can Aytu BioPharma Inc. (AY20) stock deliver consistent EPS growthTake Profit & Risk Adjusted Swing Trade Ideas - newser.com
Why Aytu BioPharma Inc. stock remains resilientQuarterly Portfolio Review & Risk Controlled Daily Trade Plans - newser.com
Does Aytu BioPharma Inc. qualify in momentum factor screening2025 Top Decliners & Verified Swing Trading Watchlist - newser.com
Will Aytu BioPharma Inc. (AY20) stock keep high P E multiplesGap Up & Entry Point Strategy Guides - newser.com
Applying Elliott Wave Theory to Aytu BioPharma Inc.Quarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
How to escape a deep drawdown in Aytu BioPharma Inc.Portfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
How to interpret RSI for Aytu BioPharma Inc. stock2025 Price Targets & Free Real-Time Volume Trigger Notifications - newser.com
Will Aytu BioPharma Inc. (AY20) stock announce a stock splitQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
Published on: 2025-11-01 08:49:06 - newser.com
Published on: 2025-11-01 06:04:31 - newser.com
Aytu Biopharma Inc Stock (AYTU) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
4.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):